Avandia + Amaryl or Avandamet Compared With Metformin: A 48-week Randomized, Open-label, Multicentre Phase IIIB Study to Compare the Effectiveness of Combination Therapy to Monotherapy in Type 2 Diabetes Mellitus Patients
Phase of Trial: Phase III
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Glimepiride; Metformin; Rosiglitazone; Rosiglitazone/metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms AVALANCHE
- 07 Jun 2017 Biomarkers information updated
- 24 Mar 2009 Actual patient number (391) added as reported by ClinicalTrials.gov.
- 09 May 2008 Status changed from in progress to completed, from clinicaltrials.gov record.